FT

German health advisers signal end of Oxford/AstraZeneca age restrictions

Similar move expected in France as EU governments come under pressure to clear stockpile of unused doses

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button